Vickers Vantage
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VCKA and buy or sell other stocks, ETFs, and their options commission-free!About VCKA
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba.
CEOHenry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees115
Employees115
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2020
Founded2020
Employees115
Employees115
VCKA Key Statistics
Market cap35.81M
Market cap35.81M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume61.81K
Average volume61.81K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$34.27
52 Week high$34.27
52 Week low$3.60
52 Week low$3.60
Stock Snapshot
As of today, Vickers Vantage(VCKA) shares are valued at $6.02. The company's market cap stands at 35.81M, with a P/E ratio of -0.54.
On 2025-12-10, Vickers Vantage(VCKA) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Vickers Vantage(VCKA) stock has reached 0, versus its average volume of 61.81K.
The stock's 52-week range extends from a low of $3.60 to a high of $34.27.
The stock's 52-week range extends from a low of $3.60 to a high of $34.27.
People also own
Based on the portfolios of people who own VCKA. This list is generated using Robinhood data, and it’s not a recommendation.